Langevin Lab

The primary focus of the Langevin laboratory is the epigenetics of disease and how it can be exploited for biomarker development.

Lab Overview

Body

Our work emphasizes non-coding RNA cargo in extracellular vesicles and DNA methylation profiles in respiratory tract cancers using next generation sequencing or high throughput methylation arrays for epigenomic profiling in human biofluids and cancer cell lines.

Lab Location

Body

323 Health Sciences Research Facility
Larner College of Medicine

Lab Members

Body

Principal Investigator

Scott Langevin, PhD, MHA, CT(ASCP) 

scott.langevin@med.uvm.edu

Dr. Langevin is a molecular epidemiologist with research interests in epigenomics of disease and environmental and occupational risk factors for cancer. He is an Associate Professor in the Division of Hematology & Oncology at the Larner College of Medicine, with a secondary appointment in the Department of Biomedical & Health Sciences in the College of Nursing and Health Sciences, and Associate Director of Community Outreach & Engagement at the University of Vermont Cancer Center.

Dr. Langevin's Publications

Postdoctoral Associates

Jimmy Vareta, PhD, MSc

jimmy.vareta@med.uvm.edu

Dr. Vareta is interested in cancer genomics and bioinformatic analysis to characterize mutational landscapes and identify genetic biomarkers for predicting treatment response and outcomes in head and neck cancer.

Dr. Vareta's Publications

Staff

Jordan Reska, B.S.

Laboratory Research Technician 

jordan.reska@med.uvm.edu